Related references
Note: Only part of the references are listed.Novel Small-Molecule Troponin Activator Increases Cardiac Contractile Function Without Negative Impact on Energetics
Huamei He et al.
CIRCULATION-HEART FAILURE (2022)
Making waves: A proposed new role for myosin-binding protein C in regulating oscillatory contractions in vertebrate striated muscle
Samantha P. Harris
JOURNAL OF GENERAL PHYSIOLOGY (2021)
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
John R. Teerlink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans
Gabor A. Fulop et al.
BASIC RESEARCH IN CARDIOLOGY (2021)
Evidence-Based Assessment of Genes in Dilated Cardiomyopathy
Elizabeth Jordan et al.
CIRCULATION (2021)
Amino terminus of cardiac myosin binding protein-C regulates cardiac contractility
Thomas L. Lynch et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2020)
Direct Sarcomere Modulators Are Promising New Treatments for Cardiomyopathies
Osamu Tsukamoto
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Epidemiology of heart failure
Amy Groenewegen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Phosphorylation of cardiac myosin-binding protein-C contributes to calcium homeostasis
Mohit Kumar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials
John R. Teerlink et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Post-translational regulation of cardiac myosin binding protein-C: A graphical review
Alice Main et al.
CELLULAR SIGNALLING (2020)
Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients With Chronic Heart Failure Results From the COSMIC-HF Study
G. Michael Felker et al.
CIRCULATION-HEART FAILURE (2020)
Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure The COSMIC-HF Trial
Tor Biering-Sorensen et al.
CIRCULATION-HEART FAILURE (2020)
Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin
Christopher N. Toepfer et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Omecamtiv Mecarbil Slows Myosin Kinetics in Skinned Rat Myocardium at Physiological Temperature
Thinh T. Kieu et al.
BIOPHYSICAL JOURNAL (2019)
Cardiac myosin binding protein-C phosphorylation regulates the super-relaxed state of myosin
James W. McNamara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Omecamtiv mercabil and blebbistatin modulate cardiac contractility by perturbing the regulatory state of the myosin filament
Thomas Kampourakis et al.
JOURNAL OF PHYSIOLOGY-LONDON (2018)
Whole length myosin binding protein C stabilizes myosin S2 as measured by gravitational force spectroscopy
Rohit R. Singh et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Omecamtiv Mecarbil Enhances the Duty Ratio of Human -Cardiac Myosin Resulting in Increased Calcium Sensitivity and Slowed Force Development in Cardiac Muscle
Anja M. Swenson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The Ca2+ sensitizer CK-2066260 increases myofibrillar Ca2+ sensitivity and submaximal force selectively in fast skeletal muscle
Darren T. Hwee et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Phosphorylation of cardiac myosin binding protein C releases myosin heads from the surface of cardiac thick filaments
Robert W. Kensler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke
John A. Rohde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes
James W. McNamara et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial
John R. Teerlink et al.
LANCET (2016)
Myosin light chain phosphorylation enhances contraction of heart muscle via structural changes in both thick and thin filaments
Thomas Kampourakis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Sarcomeric protein isoform transitions in cardiac muscle: A journey to heart failure
Zhiyong Yin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Cardiac Myosin-binding Protein C and Troponin-I Phosphorylation Independently Modulate Myofilament Length-dependent Activation
Mohit Kumar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Perturbed Length-Dependent Activation in Human Hypertrophic Cardiomyopathy With Missense Sarcomeric Gene Mutations
Vasco Sequeira et al.
CIRCULATION RESEARCH (2013)
Forecasting the Impact of Heart Failure in the United States A Policy Statement From the American Heart Association
Paul A. Heidenreich et al.
CIRCULATION-HEART FAILURE (2013)
Genetic mutations and mechanisms in dilated cardiomyopathy
Elizabeth M. McNally et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Familial hypertrophic cardiomyopathy: Functional effects of myosin mutation R723G in cardiomyocytes
Theresia Kraft et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Cardiac Myosin Binding Protein C and Its Phosphorylation Regulate Multiple Steps in the Cross-Bridge Cycle of Muscle Contraction
Arthur T. Coulton et al.
BIOCHEMISTRY (2012)
Contractile Dysfunction Irrespective of the Mutant Protein in Human Hypertrophic Cardiomyopathy With Normal Systolic Function
Sabine J. van Dijk et al.
CIRCULATION-HEART FAILURE (2012)
Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction
Suresh Govindan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Cardiac myosin binding protein C phosphorylation in cardiac disease
Diederik W. D. Kuster et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2012)
Roles for Cardiac MyBP-C in Maintaining Myofilament Lattice Rigidity and Prolonging Myosin Cross-Bridge Lifetime
Bradley M. Palmer et al.
BIOPHYSICAL JOURNAL (2011)
Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure
Fady I. Malik et al.
SCIENCE (2011)
Phosphorylation and function of cardiac myosin binding protein-C in health and disease
David Barefield et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle
O'Neal Copeland et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Discovery of Omecamtiv Mecarbil the First, Selective, Small Molecule Activator of Cardiac Myosin
Bradley P. Morgan et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Sarcomeric dysfunction in heart failure
Nazha Hamdani et al.
CARDIOVASCULAR RESEARCH (2008)
Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure
Ali El-Armouche et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Cardiac myosin binding protein C phosphorylation is cardioprotective
Sakthivel Sadayappan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy
K Haghighi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cardiac myosin-binding protein-C phosphorylation and cardiac function
S Sadayappan et al.
CIRCULATION RESEARCH (2005)
Sarcomeric protein mutations in dilated cardiomyopathy
AN Chang et al.
HEART FAILURE REVIEWS (2005)
Epidemiology of diastolic heart failure
TE Owan et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2005)
PKA accelerates rate of force development in murine skinned myocardium expressing α- or β-tropomyosin
JR Patel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)
Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy
M Kamisago et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
